Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $31.4 million.

  • GoHealth's Cash from Financing Activities rose 5457.27% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.1 million, marking a year-over-year increase of 38724.71%. This contributed to the annual value of -$32.0 million for FY2024, which is 5177.2% down from last year.
  • According to the latest figures from Q3 2025, GoHealth's Cash from Financing Activities is $31.4 million, which was up 5457.27% from $53.9 million recorded in Q2 2025.
  • Over the past 5 years, GoHealth's Cash from Financing Activities peaked at $226.3 million during Q4 2021, and registered a low of -$156.6 million during Q4 2022.
  • In the last 5 years, GoHealth's Cash from Financing Activities had a median value of -$1.1 million in 2023 and averaged $9.1 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 103615.61% in 2023, then skyrocketed by 102690.38% in 2024.
  • GoHealth's Cash from Financing Activities (Quarter) stood at $226.3 million in 2021, then crashed by 169.18% to -$156.6 million in 2022, then surged by 99.31% to -$1.1 million in 2023, then crashed by 541.12% to -$7.0 million in 2024, then surged by 550.85% to $31.4 million in 2025.
  • Its Cash from Financing Activities stands at $31.4 million for Q3 2025, versus $53.9 million for Q2 2025 and -$3.2 million for Q1 2025.